Focal embolic cerebral ischemia in the rat

Nature Protocols

Volumn 10, Issue 4, 2015, Pages 539-547

  Zhang, Li ^a   Zhang, Rui Lan ^a   Jiang, Quan ^a   Ding, Guangliang ^a   Chopp, Michael ^a,b   Zhang, Zheng Gang ^a  

^a HENRY FORD HOSPITAL   (United States)

^b OAKLAND UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY CLAMP; ARTICLE; BLOOD SAMPLING; BRAIN EMBOLISM; BRAIN INFARCTION; BRAIN ISCHEMIA; CATHETERIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; DISEASE MODEL; EXPERIMENTAL DESIGN; EXPERIMENTAL MODEL; EXPERIMENTAL RAT; FEMORAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; FIBRINOLYTIC THERAPY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE CEREBRAL ARTERY; PATHOPHYSIOLOGY; SURGERY; VASCULAR ACCESS DEVICE; WISTAR RAT;

ANIMALIA; MUS; RATTUS;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE CEREBRAL ARTERY; RATS, WISTAR; THROMBOLYTIC THERAPY; VASCULAR ACCESS DEVICES;

EID: 84925858311     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2015.036     Document Type: Article

References (65)

1. Hacke, W. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317-1329 (2008
2. Adeoye, O., Hornung, R., Khatri, P. & Kleindorfer, D. Recombinant tissue-Type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke 42, 1952-1955 (2011
3. Kleindorfer, D., Lindsell, C.J., Brass, L., Koroshetz, W. & Broderick, J.P. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. Stroke 39, 924-928 (2008
4. Fonarow, G.C. et al. Timeliness of tissue-Type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-To-needle times within 60 minutes. Circulation 123, 750-758 (2011
5. Bogousslavsky, J., Van Melle, G. & Regli, F. The Lausanne Stroke Registry: analysis of 1, 000 consecutive patients with first stroke. Stroke 19, 1083-1092 (1988
6. Dalal, P.M., Shah, P.M., Sheth, S.C. & Deshpande, C.K. Cerebral embolism. Angiographic observations on spontaneous clot lysis. Lancet 1, 61-64 (1965
7. Longa, E.Z., Weinstein, P.R., Carlson, S. & Cummins, R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84-91 (1989
8. Schmid-Elsaesser, R., Zausinger, S., Hungerhuber, E., Baethmann, A. & Reulen, H.J. A critical reevaluation of the intraluminal thread model of focal cerebral ischemia: evidence of inadvertent premature reperfusion and subarachnoid hemorrhage in rats by laser-Doppler flowmetry. Stroke 29, 2162-2170 (1998
9. Ginsberg, M.D. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 40, S111-114 (2009
10. Feuerstein, G.Z. et al. Missing steps in the STAIR case: a translational medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke. J. Cereb. Blood Flow Metab. 28, 217-219 (2008
11. O'Collins, V.E. et al. 1, 026 experimental treatments in acute stroke. Ann. Neurol. 59, 467-477 (2006
12. Lo, E.H. A new penumbra: transitioning from injury into repair after stroke. Nat. Med. 14, 497-500 (2008
13. Lo, E.H. Experimental models, neurovascular mechanisms and translational issues in stroke research. Br. J. Pharmacol. 153 (suppl. 1): S396-S405 (2008
14. Zhang, R.L., Chopp, M., Zhang, Z.G., Jiang, Q. & Ewing, J.R. A rat model of focal embolic cerebral ischemia. Brain Res. 766, 83-92 (1997
15. Zhang, Z.G. et al. Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats. J. Neurosci. 19, 10898-10907 (1999
16. Zhang, Z.G. et al. Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion. Brain Res. 912, 181-194 (2001
17. Ding, G. et al. MRI of combination treatment of embolic stroke in rat with rtPA and atorvastatin. J. Neurol. Sci. 246, 139-147 (2006
18. Zhang, R.L., Zhang, Z.G., Chopp, M. & Zivin, J.A. Thrombolysis with tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain. Stroke 30, 624-629 (1999
19. Zhang, L. et al. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Stroke 34, 1790-1795 (2003
20. Zhang, R.L., Chopp, M., Zhang, Z.G. & Divine, G. Early (1 h) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats. J. Neurol. Sci. 160, 1-8 (1998
21. Marder, V.J. et al. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 37, 2086-2093 (2006
22. Singh, P., Doostkam, S., Reinhard, M., Ivanovas, V & Taschner, C.A. Immunohistochemical Analysis of Thrombi Retrieved during Treatment of Acute Ischemic Stroke: Does Stent-retriever Cause Intimal Damage? Stroke 44, 1720-1722 (2013
23. Cheng, T. et al. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat. Med. 12, 1278-1285 (2006
24. Zhang, L. et al. Functional recovery in aged and young rats after embolic stroke: treatment with a phosphodiesterase type 5 inhibitor. Stroke 36, 847-852 (2005
25. Zhang, L. et al. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke. Circulation 107, 2837-2843 (2003
26. Zhang, Z. et al. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-Type plasminogen activator administration in a rat model of embolic stroke. Circulation 106, 740-745 (2002
27. Wilhelm-Schwenkmezger, T. et al. Therapeutic application of 20-kHz transcranial ultrasound in an embolic middle cerebral artery occlusion model in rats: safety concerns. Stroke 38, 1031-1035 (2007
28. Hobohm, C. et al. Long-lasting neuronal loss following experimental focal cerebral ischemia is not affected by combined administration of tissue plasminogen activator and hyperbaric oxygen. Brain Res. 1417, 115-126 (2011
29. Guluma, K.Z. & Lapchak, P.A. Comparison of the post-embolization effects of tissue-plasminogen activator and simvastatin on neurological outcome in a clinically relevant rat model of acute ischemic stroke. Brain Res. 1354, 206-216 (2010
30. Tanaka, Y., Marumo, T., Omura, T. & Yoshida, S. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke. Brain Res. 1154, 194-199 (2007
31. Zhang, Z.G. et al. A model of mini-embolic stroke offers measurements of the neurovascular unit response in the living mouse. Stroke 36, 2701-2704 (2005
32. Undas, A. & Ariens, R.A. Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler. Thromb. Vasc. Biol. 31, e88-99 (2011
33. Wohner, N. et al. Lytic resistance of fibrin containing red blood cells. Arterioscler. Thromb. Vasc. Biol. 31, 2306-2313 (2011
34. Zhang, Z., Chopp, M., Zhang, R.L. & Goussev, A. A mouse model of embolic focal cerebral ischemia. J. Cereb. Blood Flow Metab. 17, 1081-1088 (1997
35. Del Sette, M., Angeli, S., Stara, I., Finocchi, C. & Gandolfo, C. Microembolic signals with serial transcranial Doppler monitoring in acute focal ischemic deficit. A local phenomenon? Stroke 28, 1311-1313 (1997
36. Idicula, T.T., Naess, H & Thomassen, L. Microemboli-monitoring during the acute phase of ischemic stroke: is it worth the time? BMC Neurol. 10, 79 (2010
37. Koennecke, H.C. et al. Frequency and determinants of microembolic signals on transcranial Doppler in unselected patients with acute carotid territory ischemia. A prospective study. Cerebrovasc. Dis. 8, 107-112 (1998
38. Poppert, H., Sadikovic, S., Sander, K., Wolf, O. & Sander, D. Embolic signals in unselected stroke patients: prevalence and diagnostic benefit. Stroke 37, 2039-2043 (2006
39. Chen, J. et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682-2688 (2001
40. Hernandez, T.D. & Schallert, T. Seizures and recovery from experimental brain damage. Exp. Neurol. 102, 318-324 (1988
41. Bouet, V. et al. The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat. Protoc. 4, 1560-1564 (2009
42. Schallert, T. et al. Tactile extinction: distinguishing between sensorimotor and motor asymmetries in rats with unilateral nigrostriatal damage. Pharmacol. Biochem. Behav. 16, 455-462 (1982
43. Zhang, L. et al. Tadalafil, a long-Acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke. Brain Res. 1118, 192-198 (2006
44. Jiang, Q. et al. Magnetic resonance imaging indexes of therapeutic efficacy of recombinant tissue plasminogen activator treatment of rat at 1 and 4 hours after embolic stroke. J. Cereb. Blood Flow Metab. 20, 21-27 (2000
45. Jiang, Q. et al. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat. J. Cereb. Blood Flow Metab. 18, 758-767 (1998
46. Zhang, L. et al. Combination treatment with N-Acetyl-seryl-Aspartyl-lysyl-proline and tissue plasminogen activator provides potent neuroprotection in rats after stroke. Stroke 45, 1108-1114 (2014
47. Ding, G. et al. MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat. Neuroscience 271, 1-8 (2014
48. Zhang, L., Zhang, Z.G. & Chopp, M. The neurovascular unit and combination treatment strategies for stroke. Trends Pharmacol. Sci. 33, 415-422 (2012
49. Zhang, L. et al. Combination treatment with VELCADE and low-dose tissue plasminogen activator provides potent neuroprotection in aged rats after embolic focal ischemia. Stroke 41, 1001-1007 (2010
50. Jia, L., Chopp, M., Zhang, L., Lu, M. & Zhang, Z. Erythropoietin in combination of tissue plasminogen activator exacerbates brain hemorrhage when treatment is initiated 6 hours after stroke. Stroke 41, 2071-2076 (2010
51. Zhang, L. et al. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator. Thromb. Haemost. 95, 166-173 (2006
52. Zhang, L. et al. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-Type plasminogen activator in the rat. Circulation 112, 3486-3494 (2005
53. Ding, G. et al. Analysis of combined treatment of embolic stroke in rat with r-TPA and a GPIIb/IIIa inhibitor. J. Cereb. Blood Flow Metab. 25, 87-97 (2005
54. Zhang, L., Zhang, Z.G., Zhang, C., Zhang, R.L. & Chopp, M. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-Arterial tenecteplase-Tissue plasminogen activator in a rat stroke model. Stroke 35, 2890-2895 (2004
55. Jiang, Q. et al. MRI evaluation of treatment of embolic stroke in rat with intra-Arterial and intravenous rt-PA. J. Neurol. Sci. 224, 57-67 (2004
56. Ding, G. et al. Multiparametric ISODATA analysis of embolic stroke and rt-PA intervention in rat. J. Neurol. Sci. 223, 135-143 (2004
57. Morris, D.C. et al. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke. Stroke 32, 2635-2640 (2001
58. Zhang, R.L. et al. Postischemic intracarotid treatment with TNK-TPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat. Brain Res. 878, 64-71 (2000
59. Nakayama, H., Dietrich, W.D., Watson, B.D., Busto, R. & Ginsberg, M.D. Photothrombotic occlusion of rat middle cerebral artery: histopathological and hemodynamic sequelae of acute recanalization. J. Cereb. Blood Flow Metab. 8, 357-366 (1988
60. Watson, B.D., Dietrich, W.D., Busto, R., Wachtel, M.S. & Ginsberg, M.D. Induction of reproducible brain infarction by photochemically initiated thrombosis. Ann. Neurol. 17, 497-504 (1985
61. Zivin, J.A. et al. A model for quantitative evaluation of embolic stroke therapy. Brain Res. 435, 305-309 (1987
62. Gerriets, T. et al. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J. Neurosci. Methods 122, 201-211 (2003
63. Kudo, M., Aoyama, A., Ichimori, S. & Fukunaga, N. An animal model of cerebral infarction. Homologous blood clot emboli in rats. Stroke 13, 505-508 (1982
64. Overgaard, K. et al. A rat model of reproducible cerebral infarction using thrombotic blood clot emboli. J. Cereb. Blood Flow Metab. 12, 484-490 (1992
65. Benes, V., Zabramski, J.M., Boston, M., Puca, A & Spetzler, R.F. Effect of intra-Arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected]. Stroke 21, 1594-1599 (1990